Company intelligence / Profile preview

Primix Bioventures

Kortenberg, Flemish Brabant, Belgiumannualreports.com ↗

Ownership: Private
Development stage: Other

Overview

Primix Bioventures is a Belgium-based life sciences investment and development company focused on supporting early-stage drug development companies, particularly those with novel science addressing significant unmet medical needs. It operates as part of the Droia Ventures network, which specializes in therapeutics for oncology and genetic diseases[5]. There is no direct evidence that it runs its own clinical trials or has its own pipeline assets; rather, it supports portfolio companies through investment and operational expertise[5].

Industry: Investors

Partnerships

Droia Labs (scientific arm of Droia Ventures)Portfolio companies supported by Droia/Primix

Beyond the preview

Go deeper on Primix Bioventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primix Bioventures.

Explore the full profile